Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth.
Saved in:
| Title: | Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth. |
|---|---|
| Authors: | Cornelius P; SynDevRx, Inc., Cambridge, MA, United States., Mayes BA; SynDevRx, Inc., Cambridge, MA, United States., Dannenberg AJ; Emerald Bioventures, New York, NY, United States., Dufour PJ; SynDevRx, Inc., Cambridge, MA, United States., Little S; Neosome Life Sciences, Billerica, MA, United States., Guzior DV; Panome Bio, St. Louis, MO, United States., Petersen JS; SynDevRx, Inc., Cambridge, MA, United States., Shanahan JM; SynDevRx, Inc., Cambridge, MA, United States., Carver BJ; SynDevRx, Inc., Cambridge, MA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Feb 18; Vol. 16, pp. 1751681. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1751681 |
